Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Patients with systemic lupus erythematosus and hair loss had non-scarring alopecia with fewer hair follicles, and direct immunofluorescence did not help identify lupus.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

New hair treatment methods are evolving, with microneedling as a promising technique for hair growth.

A patient with a skin condition had unusual scarring hair loss but improved with treatment.

Reduced Stx17 expression may contribute to Alopecia Areata.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

Deep learning can improve non-invasive alopecia diagnosis using hair images.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

Some breast cancer chemotherapy can cause permanent hair loss.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

Hair care practices like using relaxers and tight braiding can lead to permanent hair loss in black women.

Horizontal scalp biopsy sections effectively diagnose and predict MPAA, with follicular density and inflammation impacting hair regrowth.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Finasteride works for hair loss by maintaining existing hair follicles, not reversing miniaturization.